Antimicrobial Activity of Plants Against Emerging or Drug-Resistant Human Pathogens
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Plant-Derived Antibiotics".
Deadline for manuscript submissions: closed (30 April 2025) | Viewed by 1498
Special Issue Editors
Interests: medicinal plants as sources of antibacterial, antiprotozoal and antidiabetic agents; antimicrobial resistance of group ESKAPE-E; clinical and epidemiological study of bacterial diseases
Interests: clinical and molecular epidemiology of emerging, re-emerging, and healthcare-associated infections; development of new agents against multidrug-resistant mycobacterium tuberculosis and ESKAPE-E bacteria; ethnopharmacological study of Mayan medicinal plants for anti-infective properties
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Pathogens, including bacteria, fungi, protozoa, helminths, and viruses, are responsible for millions of human fatalities. Coronavirus disease (COVID-19) and tuberculosis remain among the top 10 causes of global mortality. Furthermore, it is estimated that between now and 2050, more than 39 million individuals will die of antibiotic-resistant infections. Despite the availability of various drugs for infectious diseases, there is an urgent need for the development of novel therapies for emerging diseases, as well as for infections for which antibiotics are no longer effective due to antimicrobial resistance. Historically, plants have served as valuable sources of anti-infective agents, and numerous drugs used in contemporary medicine originate from botanical sources. The estimated number of plant species on Earth ranges from 250,000 to 500,000, many of which are utilized for medicinal purposes and are part of the healthcare systems in developing countries. In recent years, research has focused on the identification of plant extracts with activity against pathogens, with the objective of developing new phytodrugs. This Special Issue of Antibiotics presents the most recent research on plant extracts and their antimicrobial activities against emerging and drug-resistant pathogens.
Dr. Andrés H. Uc-Cachón
Dr. Gloria María Molina-Salinas
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- anti-infective agents
- antimicrobial activity
- human pathogens
- medicinal plants
- natural products
- phytodrugs
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
